Ignite Creation Date:
2024-05-06 @ 7:04 PM
Last Modification Date:
2024-10-26 @ 2:59 PM
Study NCT ID:
NCT05882006
Status:
RECRUITING
Last Update Posted:
2023-07-21
First Post:
2023-05-21
Brief Title:
Gallstones and Risk of Inflammatory Bowel Disease
Sponsor:
Hepatopancreatobiliary Surgery Institute of Gansu Province
Organization:
Hepatopancreatobiliary Surgery Institute of Gansu Province
Study Overview
Official Title:
A Multicenter Case-control Study of the Association Between the Presence of Gallstone Disease and Risk of Inflammatory Bowel Disease
Status:
RECRUITING
Status Verified Date:
2023-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study was to evaluate the association between gallstone disease and the risk of inflammatory bowel disease
Detailed Description:
Crohns disease and ulcerative colitis collectively known as inflammatory bowel diseases have increased substantially over the past few decades affecting nearly 68 million individuals worldwide The etiology of IBD remains obscure possibly involving a complex interaction between the genetic environmental or microbial factors and the immune responses Gallstone disease is one of the most common and costly gastroenterological disorders with a prevalence of 10-20 in Europe and America Considering that gallstones and IBD also share specific risk factors such as obesity inappropriate diet and metabolic hormone levels and have the pathophysiologic linkage such as changes in gut microbiota composition and bile acid profile the investigators propose that the occurrence of gallstones may predict the subsequence risk of IBD However investigations concerning the association is lacking
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None